The genomic landscape of pediatric renal cell carcinomas.

Cancer Genomics

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
15 Apr 2022
Historique:
received: 16 11 2021
revised: 03 03 2022
accepted: 24 03 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

Pediatric renal cell carcinomas (RCC) differ from their adult counterparts not only in histologic subtypes but also in clinical characteristics and outcome. However, the underlying biology is still largely unclear. For this reason, we performed whole-exome and transcriptome sequencing analyses on a cohort of 25 pediatric RCC patients with various histologic subtypes, including 10 MiT family translocation (MiT) and 10 papillary RCCs. In this cohort of pediatric RCC, we find only limited genomic overlap with adult RCC, even within the same histologic subtype. Recurrent somatic mutations in genes not previously reported in RCC were detected, such as in

Identifiants

pubmed: 35445187
doi: 10.1016/j.isci.2022.104167
pii: S2589-0042(22)00437-0
pmc: PMC9014386
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104167

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

N Engl J Med. 2016 Jan 14;374(2):135-45
pubmed: 26536169
Am J Surg Pathol. 2020 Jul;44(7):e47-e65
pubmed: 32251007
Int J Mol Sci. 2020 Jun 30;21(13):
pubmed: 32630154
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Mol Cancer Ther. 2020 Nov;19(11):2235-2244
pubmed: 32967924
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
J Biol Chem. 2019 Jun 7;294(23):9029-9036
pubmed: 31018963
PLoS One. 2018 Oct 3;13(10):e0204912
pubmed: 30281678
J Cell Biochem. 2014 May;115(5):819-25
pubmed: 24356912
Fam Cancer. 2018 Jan;17(1):135-139
pubmed: 28623476
Eur Urol Focus. 2017 Dec;3(6):584-589
pubmed: 28753846
Ann Oncol. 2020 Sep;31(9):1240-1250
pubmed: 32473302
Cancer. 2020 Dec 1;126(23):5156-5164
pubmed: 32926409
Hematol Oncol. 2017 Dec;35(4):760-768
pubmed: 27282883
Mol Cancer Res. 2019 Aug;17(8):1613-1626
pubmed: 31043488
Am J Surg Pathol. 2008 May;32(5):656-70
pubmed: 18344867
Cell Rep. 2016 Mar 15;14(10):2476-89
pubmed: 26947078
JAMA Oncol. 2018 Sep 1;4(9):1228-1235
pubmed: 29978187
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Semin Cancer Biol. 2013 Feb;23(1):46-55
pubmed: 22705279
Transl Oncol. 2020 Feb;13(2):336-345
pubmed: 31881506
Cancer Cell Int. 2020 Jan 28;20:27
pubmed: 32002016
J Natl Compr Canc Netw. 2014 Sep;12(9):1347-55
pubmed: 25190700
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
Carcinogenesis. 2007 Sep;28(9):2028-35
pubmed: 17389615
Mol Oncol. 2015 Oct;9(8):1667-77
pubmed: 26051997
Commun Biol. 2021 Jan 4;4(1):22
pubmed: 33398073
Genome Res. 2021 Mar;31(3):448-460
pubmed: 33441414
Clin Exp Pharmacol Physiol. 2017 Aug;44(8):841-846
pubmed: 28556374
Kidney Cancer. 2020 Sep 16;4(3):121-129
pubmed: 33195887
Nat Immunol. 2019 Nov;20(11):1425-1434
pubmed: 31611702
Int J Mol Med. 2018 Dec;42(6):3105-3114
pubmed: 30272265
Fam Cancer. 2020 Jan;19(1):55-63
pubmed: 31792767
Pathol Int. 2018 Sep;68(9):541-542
pubmed: 29935000
Genome Med. 2019 May 24;11(1):34
pubmed: 31126321
Genome Biol. 2014;15(12):550
pubmed: 25516281
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Cell. 2015 Jan 15;160(1-2):48-61
pubmed: 25594174
Cancer Genet. 2020 Jun;244:40-54
pubmed: 32434132
Evol Dev. 2020 Jul;22(4):297-311
pubmed: 32163674
Cancers (Basel). 2021 Jan 10;13(2):
pubmed: 33435262
Curr Opin Oncol. 2019 May;31(3):194-199
pubmed: 30985497
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12426-31
pubmed: 23836671
Cancer. 2006 Dec 15;107(12):2906-14
pubmed: 17109448
Cancer. 2004 Oct 1;101(7):1575-83
pubmed: 15378495
Nat Genet. 2014 Aug;46(8):912-918
pubmed: 25017105
Clin Cancer Res. 2014 Jul 1;20(13):3411-21
pubmed: 24658158
Cell. 2017 May 4;169(4):736-749.e18
pubmed: 28475899
Mod Pathol. 2021 Jul;34(7):1392-1424
pubmed: 33664427
Clin Cancer Res. 2014 Aug 1;20(15):4129-40
pubmed: 24899691
Nature. 2012 Aug 2;488(7409):100-5
pubmed: 22832583
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635225
Neoplasia. 2018 Jan;20(1):99-117
pubmed: 29245123
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873
pubmed: 27100738
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Neoplasia. 2013 Nov;15(11):1231-40
pubmed: 24339735
Transl Oncol. 2021 Apr;14(4):101033
pubmed: 33571850
Nat Genet. 2011 Dec 25;44(2):165-9
pubmed: 22197930
Nature. 2018 Mar 15;555(7696):371-376
pubmed: 29489755
Cell Rep. 2018 Apr 3;23(1):313-326.e5
pubmed: 29617669
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Nat Cancer. 2021 Dec;1(12):1188-1203
pubmed: 33834176
Am J Surg Pathol. 2019 Jan;43(1):121-131
pubmed: 30303819
J Pathol. 2018 Apr;244(5):525-537
pubmed: 29266437
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Commun. 2016 Oct 11;7:13103
pubmed: 27725675
Biochem Biophys Res Commun. 2009 Dec 4;390(1):109-14
pubmed: 19782049
PLoS One. 2014 Mar 24;9(3):e92815
pubmed: 24664224
Cell Death Dis. 2017 May 18;8(5):e2793
pubmed: 28518146
Mod Pathol. 2014 Jun;27(6):875-86
pubmed: 24309327
Genes Chromosomes Cancer. 2021 May;60(5):314-331
pubmed: 33222322
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Hum Mol Genet. 2012 Dec 15;21(24):5329-43
pubmed: 22962313
Cancer. 2015 Jul 15;121(14):2457-64
pubmed: 25845370
Nature. 2015 Jul 9;523(7559):149-51
pubmed: 26156357
Cancer. 2018 Aug;124(16):3381-3389
pubmed: 29905933
Exp Ther Med. 2018 Dec;16(6):5318-5326
pubmed: 30542490
Genes (Basel). 2020 Jul 24;11(8):
pubmed: 32722212
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
Mol Aspects Med. 2019 Oct;69:10-26
pubmed: 30862463
Clin Cancer Res. 2020 Jul 15;26(14):3629-3640
pubmed: 32220885
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Int J Mol Sci. 2019 Jul 24;20(15):
pubmed: 31344914
Biomed Res Int. 2020 Mar 19;2020:5264265
pubmed: 32280689
Semin Oncol. 2016 Oct;43(5):566-574
pubmed: 27899189
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Nat Genet. 2015 Jan;47(1):13-21
pubmed: 25401301
Int Urol Nephrol. 2014 Nov;46(11):2127-32
pubmed: 25000896
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Brain Tumor Res Treat. 2019 Apr;7(1):33-38
pubmed: 31062529
Front Cell Neurosci. 2020 Jul 28;14:158
pubmed: 32848606
Front Genet. 2019 Dec 03;10:1180
pubmed: 31850059
Nature. 2013 Oct 17;502(7471):333-339
pubmed: 24132290
Mod Pathol. 2012 Feb;25(2):308-15
pubmed: 22037260
Int J Cancer. 2021 Jun 1;148(11):2724-2735
pubmed: 33460450
Int J Urol. 2018 Sep;25(9):780-786
pubmed: 30066367
Cancers (Basel). 2019 Aug 03;11(8):
pubmed: 31382581
Front Oncol. 2020 Jan 10;9:1494
pubmed: 31998647
Pathology. 2020 Apr;52(3):297-309
pubmed: 32107074
Front Oncol. 2020 Aug 25;10:1527
pubmed: 32984002
Bioinformatics. 2015 Jun 15;31(12):2032-4
pubmed: 25697820
Cancer. 2015 Jan 15;121(2):269-75
pubmed: 25224030
Cell Mol Neurobiol. 2015 Aug;35(6):785-95
pubmed: 25772140
Cancer Genomics Proteomics. 2019 May-Jun;16(3):147-153
pubmed: 31018945
NAR Genom Bioinform. 2020 Sep;2(3):lqaa078
pubmed: 33015620
Br J Cancer. 2017 Mar 28;116(7):937-943
pubmed: 28253524
Oncogene. 2018 Feb 8;37(6):756-767
pubmed: 29059151

Auteurs

Pengbo Beck (P)

Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

Barbara Selle (B)

Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Lukas Madenach (L)

Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

David T W Jones (DTW)

Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Pediatric Glioma Research Group, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Christian Vokuhl (C)

Section of Pediatric Pathology, Department of Pathology, University Hospital Bonn, Bonn, Germany.

Apurva Gopisetty (A)

Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

Arash Nabbi (A)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Ines B Brecht (IB)

Department of Pediatric Oncology and Hematology, University Children's Hospital Tübingen, Tübingen, Germany.

Martin Ebinger (M)

Department of Pediatric Oncology and Hematology, University Children's Hospital Tübingen, Tübingen, Germany.

Jenny Wegert (J)

Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, Würzburg University & Comprehensive Cancer Center Mainfranken, Würzburg, Germany.

Norbert Graf (N)

Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany.

Manfred Gessler (M)

Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, Würzburg University & Comprehensive Cancer Center Mainfranken, Würzburg, Germany.

Stefan M Pfister (SM)

Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Heidelberg, Germany.

Natalie Jäger (N)

Hopp Children's Cancer Center Heidelberg (KiTZ) & Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Classifications MeSH